Updated June 7 North Liberty’s proposal to bring a 500,000-square-foot, state-of-the-art manufacturing facility — equal to $650 million in a total capital investment — was narrowly rejected by Scorpion Biological Services in favor of a plan from Manhattan, Kansas. Scorpion, a contract development and manufacturing organization (CDMO) and subsidiary of NightHawk Biosciences (formerly known as … Continue reading North Liberty narrowly fails in $650M biomanufacturing facility bid